SLC5A2 and cystinuria: Thus, a phase 2 clinical trial is underway to test the efficacy of dapagliflozin, an inhibitor of the proximal tubule’s sodium-glucose cotransporter 2 (SGLT-2), in patients with cystinuria [41].